GENEVA—Alcon (SIX/NYSE:ALC), a global leader in eyecare, announced its financial results for the three months ending March 31, 2026. For the first quarter of 2026, sales were $2.7 billion, up 10 percent on a reported basis and up 6 percent on a constant currency basis, as compared with the same quarter of the previous year. Vision care net sales, which include contact lenses and ocular health, reached $1.2 billion, an increase of 9 percent on a reported basis and 6 percent on a constant currency basis compared with the first quarter of 2025, the announcement noted.